Several disulfide-based and azoic compounds have shown antiviral and virucidal properties against arenaviruses in virus yield-inhibition and inactivation assays, respectively. The most effective virucidal agent, the aromatic disulfide NSC20625, was able to inactivate two strains of the prototype arenavirus species Lymphocytic choriomeningitis virus (LCMV). Inactivated viral particles retained the biological functions of the virion envelope glycoproteins in virus binding and uptake, but were unable to perform viral RNA replication. Furthermore, in inactivated virions, the electrophoretic profile of the Z protein was altered when analysed under non-reducing conditions, whereas the patterns of the proteins NP and GP1 remained unaffected. Treatment of a recombinant LCMV Z protein with the virucidal agents induced unfolding and oligomerization of Z to high-molecular-mass aggregates, probably due to metal-ion ejection and the formation of intermolecular disulfide bonds through the cysteine residues of the Z RING finger. NSC20625 also exhibited antiviral properties in LCMV-infected cells without affecting other cellular RING-motif proteins, such as the promyelocytic leukaemia protein PML. Altogether, the investigations described here illustrate the potential of the Z protein as a promising target for therapy and the prospects of the Z-reactive compounds to prevent arenavirus dissemination.
AuperinD. D.,
RomanowskiV.,
GalinskiM.,
BishopD. H. L.1984; Sequencing studies of Pichinde arenavirus S RNA indicate a novel coding strategy, an ambisense viral S RNA. J Virol 52:897–904
BartolottaS.,
GarcíaC. C.,
CandurraN. A.,
DamonteE. B.2001; Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol 146:777–790[CrossRef]
BordenK. L. B.,
BoddyM. N.,
LallyJ.,
O'ReillyN. J.,
MartinS.,
HoweK.,
SolomonE.,
FreemontP. S.1995; The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14:1532–1541
BordenK. L. B.,
Campbell DwyerE. J.,
CarlileG. W.,
DjavaniM.,
SalvatoM. S.1998a; Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 72:3819–3826
BordenK. L. B.,
Campbell DwyerE. J.,
SalvatoM. S.1998b; An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72:758–766
BurnsN. J.III,
BarnettB. B.,
HuffmanJ. H.,
DawsonM. I.,
SidwellR. W.,
De ClercqE.,
KendeM.1988; A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues. Antiviral Res 10:89–98[CrossRef]
Campbell DwyerE. J.,
LaiH.,
MacDonaldR. C.,
SalvatoM. S.,
BordenK. L. B.2000; The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J Virol 74:3293–3300[CrossRef]
CapiliA. D.,
SchultzD. C.,
RauscherF. J.III,
BordenK. L. B.2001; Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J 20:165–177[CrossRef]
CastillaV.,
BarqueroA. A.,
MersichS. E.,
CotoC. E.1998; In vitro anti-Junin virus activity of a peptide isolated from Melia azedarach L. leaves. Int J Antimicrob Agents 10:67–75[CrossRef]
CharrelR. N.,
LemassonJ.-J.,
GarbuttM.,
KhelifaR.,
De MiccoP.,
FeldmannH.,
de LamballerieX.2003; New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. Virology 317:191–196[CrossRef]
CornuT. I.,
de la TorreJ. C.2001; RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J Virol 75:9415–9426[CrossRef]
CornuT. I.,
de la TorreJ. C.2002; Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis. J Virol 76:6678–6688[CrossRef]
DamonteE. B.,
MersichS. E.,
CandurraN. A.1994; Intracellular processing and transport of Junin virus glycoproteins influences virion infectivity. Virus Res 34:317–326[CrossRef]
DjavaniM.,
TopisirovicI.,
ZapataJ. C.& 8 other authors2005; The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. J Virol 79:2461–2473[CrossRef]
EichlerR.,
LenzO.,
StreckerT.,
EickmannM.,
KlenkH.-D.,
GartenW.2003a; Identification of Lassa virus glycoprotein signal peptide as a trans -acting maturation factor. EMBO Rep 4:1084–1088[CrossRef]
EichlerR.,
LenzO.,
StreckerT.,
GartenW.2003b; Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 538:203–206[CrossRef]
EichlerR.,
StreckerT.,
KolesnikovaL.,
ter MeulenJ.,
WeissenhornW.,
BeckerS.,
KlenkH. D.,
GartenW.,
LenzO.2004; Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP. Virus Res 100:249–255[CrossRef]
Franze-FernándezM. T.,
IapalucciS.,
LópezN.,
RossiC.1993; Subgenomic RNAs of Tacaribe virus. In The Arenaviridae pp 113–132 Edited by
SalvatoM. S.
New York: Plenum;
GarcíaC. C.,
CandurraN. A.,
DamonteE. B.2000; Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds. Antivir Chem Chemother 11:231–238[CrossRef]
GarcíaC. C.,
RossoM. L.,
BertoniM. D.,
MaierM. S.,
DamonteE. B.2002b; Evaluation of the antiviral activity against Junin virus of macrocyclic trichothecenes produced by the hypocrealean epibiont of Baccharis coridifolia
. Planta Med 68:209–212[CrossRef]
GarcíaC. C.,
CandurraN. A.,
DamonteE. B.2003b; Differential inhibitory action of two azoic compounds against arenaviruses. Int J Antimicrob Agents 21:319–324[CrossRef]
GarcinD.,
RochatS.,
KolakofskyD.1993; The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication. J Virol 67:807–812
Grande-PérezA.,
LázaroE.,
LowensteinP.,
DomingoE.,
ManrubiaS. C.2005; Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A 102:4448–4452[CrossRef]
GuillermG.,
GuillermD.,
Vandenplas-VitkowskiC.,
GlapskiC.,
De ClercqE.2003; Inactivation of S -adenosyl-l-homocysteine hydrolase with novel 5′-thioadenosine derivatives. Antiviral effects. Bioorg Med Chem Lett 13:1649–1652[CrossRef]
HugginsJ. W.,
RobinsR. K.,
CanonicoP. G.1984; Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob Agents Chemother 26:476–480[CrossRef]
LópezN.,
JácamoR.,
Franze-FernándezM. T.2001; Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75:12241–12251[CrossRef]
Miller JenkinsL. M.,
ByrdJ. C.,
HaraT.& 7 other authors2005; Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters. J Med Chem 48:2847–2858[CrossRef]
NeumanB. W.,
AdairB. D.,
BurnsJ. W.,
MilliganR. A.,
BuchmeierM. J.,
YeagerM.2005; Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J Virol 79:3822–3830[CrossRef]
PerezM.,
CravenR. C.,
de la TorreJ. C.2003; The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 100:12978–12983[CrossRef]
PerezM.,
GreenwaldD. L.,
de la TorreJ. C.2004; Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol 78:11443–11448[CrossRef]
ReinA.,
OttD. E.,
MirroJ.,
ArthurL. O.,
RiceW.,
HendersonL. E.1996; Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein. J Virol 70:4966–4972
RiceW. G.,
TurpinJ. A.,
SchaefferC. A.& 7 other authors1996; Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J Med Chem 39:3606–3616[CrossRef]
RotzL. D.,
KhanA. S.,
LillibridgeS. R.,
OstroffS. M.,
HughesJ. M.2002; Public health assessment of potential biological terrorism agents. Emerg Infect Dis 8:225–230[CrossRef]
SalvatoM. S.1993; Molecular biology of the prototype arenavirus, lymphocytic choriomeningitis virus. In The Arenaviridae pp 133–156 Edited by
SalvatoM. S.
New York: Plenum;
SalvatoM. S.,
ShimomayeE. M.1989; The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology 173:1–10[CrossRef]
SalvatoM. S.,
SchweighoferK. J.,
BurnsJ.,
ShimomayeE. M.1992; Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res 22:185–198[CrossRef]
SalvatoM. S.,
CleggJ. C. S.,
BuchmeierM. J.,
CharrelR. N.,
GonzalezJ.-P.,
LukashevichI. S.,
PetersC. J.,
Rico-HesseR.,
RomanowskiV.2005; Arenaviridae
. In Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses pp 725–733 Edited by
FauquetC. M.,
MayoM. A.,
ManiloffJ.,
DesselbergerU.,
BallL. A.
London: Elsevier/Academic Press;
SánchezA. B.,
PerezM.,
CornuT.,
de la TorreJ. C.2005; RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 79:11071–11081[CrossRef]
SmeeD. F.,
MorrisJ. L.,
BarnardD. L.,
Van AerschotA.1992; Selective inhibition of arthropod-borne and arenaviruses in vitro by 3′-fluoro-3′-deoxyadenosine. Antiviral Res 18:151–162[CrossRef]
SmeeD. F.,
GilbertJ.,
LeonhardtJ. A.,
BarnettB. B.,
HugginsJ. H.,
SidwellR. W.1993; Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res 20:57–70
StreckerT.,
EichlerR.,
ter MeulenJ.,
WeissenhornW.,
KlenkH. D.,
GartenW.,
LenzO.2003; Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles. J Virol 77:10700–10705[CrossRef]
TopisirovicI.,
CapiliA. D.,
BordenK. L. B.2002; Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner. Mol Cell Biol 22:6183–6198[CrossRef]
TortoriciM. A.,
GhiringhelliP. D.,
LozanoM. E.,
AlbariñoC. G.,
RomanowskiV.2001; Zinc-binding properties of Junín virus nucleocapsid protein. J Gen Virol 82:121–128
TumminoP. J.,
HarveyP. J.,
McQuadeT.,
DomagalaJ.,
GogliottiR.,
SanchezJ.,
SongY.,
HupeD.1997; The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. Antimicrob Agents Chemother 41:394–400
TurpinJ. A.,
SongY.,
InmanJ. K.,
HuangM.,
WallqvistA.,
MaynardA.,
CovellD. G.,
RiceW. G.,
AppellaE.1999; Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J Med Chem 42:67–86[CrossRef]
UckunF. M.,
PetkevichA. S.,
VassilevA. O.,
TibblesH. E.,
TitovL.2004; Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by Lassa virus. BMC Infect Dis 4:1[CrossRef]
WachsmanM. B.,
LópezE. M. F.,
RamírezJ. A.,
GalagovskyL. R.,
CotoC. E.2000; Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antivir Chem Chemother 11:71–77[CrossRef]
WitvrouwM.,
DesmyterJ.,
De ClercqE.1994; Antiviral portrait series. 4. Polysulfates as inhibitors of HIV and other enveloped viruses. Antivir Chem Chemother 5:345–359[CrossRef]